|
Video: What is a Stock Split?
|
|
Bacterin International Holdings, through its Bacterin International, Inc. is engaged in biomaterials research, development, and commercialization. Co. manufactures and sells several human tissue-based products, primarily allografts, into the medical marketplace through its biologics division. Co.'s biologics products include OsteoSponge®, OsteoSponge®SC, OsteoWrap®, OsteoLock®, BacFast® HD, OsteoSTXTM and hMatrix®. In addition, Co. researches, tests and develops coatings for medical devices including various coating and surgical drain products through its medical devices division. This division produces and distributes OsteoSelect® DBM putty, which is used as a bone void filler. According to our BONE split history records, BONE has had 1 split. | |
|
BONE (BONE) has 1 split in our BONE split history database. The split for BONE took place on July 28, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of BONE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as BONE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BONE split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BONE shares, starting with a $10,000 purchase of BONE, presented on a split-history-adjusted basis factoring in the complete BONE split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/10/2014 |
|
End date: |
10/16/2015 |
|
Start price/share: |
$3.80 |
|
End price/share: |
$3.25 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-14.47% |
|
Average Annual Total Return: |
-14.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,552.34 |
|
Years: |
1.02 |
|
|
|
Date |
Ratio |
07/28/2014 | 1 for 10 |
|
|